Cargando…
Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
BACKGROUND: Osteosarcoma (OS) is the most common primary aggressive sarcoma of bone, with massive aberrant expression of oncogenes related to the development of OS. RALA, a kind of small Ras-like guanosine triphosphatases, has been identified as a potential therapeutic target in several types of tum...
Autores principales: | Fan, Gentao, Zhu, Yan, Zhu, Hao, Yu, Lingfeng, Wang, Zhen, Zhai, Chenjun, Zhou, Guangxin, Zhao, Jianning, Wang, Yicun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936457/ https://www.ncbi.nlm.nih.gov/pubmed/36817861 http://dx.doi.org/10.1155/2023/1150768 |
Ejemplares similares
-
Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling
por: Yu, Lingfeng, et al.
Publicado: (2022) -
PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
por: Wang, Zhen, et al.
Publicado: (2022) -
In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy
por: Yu, Lingfeng, et al.
Publicado: (2023) -
MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2
por: Ling, Zhonghua, et al.
Publicado: (2020) -
LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p
por: Wang, Zhen, et al.
Publicado: (2022)